Literature DB >> 19139190

Role of complement in host defense against pneumococcal otitis media.

Vishakha Sabharwal1, Sanjay Ram, Marisol Figueira, In Ho Park, Stephen I Pelton.   

Abstract

Strategies to limit complement deposition on Streptococcus pneumoniae are established as virulence features for invasive disease, but their role in respiratory tract infection requires further analysis. We evaluated complement C3 protein deposition on discordant S. pneumoniae isolates of the same serotype (6A) and their capacity to cause nasopharyngeal (NP) colonization and experimental otitis media (EOM) in an animal model. We compared C3 binding to five 6A isolates from asymptomatic NP carriers with five 6A strains that caused invasive disease, and we observed less C3 ( approximately 10-fold less fluorescence) binding to invasive isolates. We selected two high-level C3-binding carriage and two low-level C3-binding invasive 6A isolates for further study. In the EOM model, 11/12 (92%) ears challenged with a low-level C3-binding 6A strain became infected. Only 2/8 (25%) ears challenged with the discordant high-level C3-binding 6A isolate developed disease (P = 0.005). Results with the second discordant 6A isolate pair were comparable. Cobra venom factor (CoVF) treatment, which depletes C3 and consumes complement, restored virulence of the high-level C3-binding strain; 8/8 (100%) ears in CoVF-treated animals developed EOM compared to only 25% of ears in naïve animals (P = 0.007). These studies demonstrate the critical role for complement evasion in pneumococcal EOM. Colonization with carriage isolates that bound high levels of C3 caused EOM in fewer animals compared to low-level C3-binding invasive strains. Thus, limiting C3 deposition on the surface of S. pneumoniae correlates with increased incidence of EOM following NP colonization and barotrauma in the animal model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139190      PMCID: PMC2643640          DOI: 10.1128/IAI.01148-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H.

Authors:  Lisa R Quin; Chinwendu Onwubiko; Stephanie Carmicle; Larry S McDaniel
Journal:  FEMS Microbiol Lett       Date:  2006-11       Impact factor: 2.742

2.  Degradation of C3 by Streptococcus pneumoniae.

Authors:  C S Angel; M Ruzek; M K Hostetter
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

3.  PspC, a pneumococcal surface protein, binds human factor H.

Authors:  S Dave; A Brooks-Walter; M K Pangburn; L S McDaniel
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  In vivo binding of complement regulator factor H by Streptococcus pneumoniae.

Authors:  Lisa R Quin; Stephanie Carmicle; Sandhya Dave; Michael K Pangburn; Jason P Evenhuis; Larry S McDaniel
Journal:  J Infect Dis       Date:  2005-10-26       Impact factor: 5.226

5.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR.

Authors:  J Yu; M da G S Carvalho; B Beall; M H Nahm
Journal:  J Med Microbiol       Date:  2008-02       Impact factor: 2.472

7.  Immunologic studies in pneumococcal disease.

Authors:  T H Dee; G Schiffman; M I Sottile; M W Rytel
Journal:  J Lab Clin Med       Date:  1977-06

8.  Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.

Authors:  Jie Li; Alexander J Szalai; Susan K Hollingshead; Moon H Nahm; David E Briles
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

9.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

10.  Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.

Authors:  Marisol A Figueira; Sanjay Ram; Richard Goldstein; Derek W Hood; E Richard Moxon; Stephen I Pelton
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

View more
  24 in total

Review 1.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

3.  Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  M Figueira; P Fernandes; S I Pelton
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models.

Authors:  Hongmei Xu; Libin Wang; Jian Huang; Yanqing Zhang; Feng Ma; Jianmin Wang; Wenchun Xu; Xuemei Zhang; Yibing Yin; Kaifeng Wu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

5.  Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.

Authors:  Qian Li; Yong Xing Li; Kelsey Douthitt; Gregory L Stahl; Joshua M Thurman; Hua Hua Tong
Journal:  Microbes Infect       Date:  2012-08-30       Impact factor: 2.700

6.  Nontypeable Streptococcus pneumoniae as an otopathogen.

Authors:  Qingfu Xu; Ravinder Kaur; Janet R Casey; Vishakha Sabharwal; Stephen Pelton; Michael E Pichichero
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

7.  Treatment of otitis media by transtympanic delivery of antibiotics.

Authors:  Rong Yang; Vishakha Sabharwal; Obiajulu S Okonkwo; Nadya Shlykova; Rong Tong; Lily Yun Lin; Weiping Wang; Shutao Guo; John J Rosowski; Stephen I Pelton; Daniel S Kohane
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

8.  Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics.

Authors:  Rong Yang; Vishakha Sabharwal; Nadya Shlykova; Obiajulu S Okonkwo; Stephen I Pelton; Daniel S Kohane
Journal:  JCI Insight       Date:  2018-10-04

9.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

10.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.